FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386531127> ?p ?o ?g. }

• W4386531127 abstract "Much of the current literature on treatment patterns and disability progression in multiple sclerosis (MS) does not distinguish between the relapsing-remitting and progressive subtypes (including primary [PPMS] and secondary progressive MS [SPMS]), or between active/nonactive disease. Current treatment options for progressive MS are limited, with only one approved product for PPMS and none specifically for nonactive SPMS. Here we report treatment patterns, disability progression, and unmet needs among patients with active and nonactive PPMS and SPMS.The annual, cross-sectional survey from the Adelphi Disease Specific Program was used to collect physician-reported data on US adult patients with PPMS and SPMS, including active and nonactive disease. Treatment patterns (including the proportion of patients who were untreated with a disease-modifying therapy [DMT]), disability progression, and unmet need are described from 2016 to 2021.Data were collected for 2067 patients with progressive MS (PPMS, 1583; SPMS, 484). A substantial proportion of patients were untreated across all groups, and this was highest for nonactive PPMS (~ 43%). The proportion of untreated patients generally declined over time but remained high in 2018-2021 (~ 10-38%). Among treated patients, the proportion receiving infusions increased over time to ~ 34-46%, largely driven by ocrelizumab use after approval. Disability progression was reported for most patients (> 50%), including many who were receiving a DMT. Across all disease subtypes, when physicians were asked about the greatest unmet need with current DMTs, they most frequently cited effectiveness (~ 63-87%), and specifically slowing disease progression (~ 32-59%).This analysis of physician-reported data reveals that patients with progressive MS, particularly those with nonactive disease, frequently remain untreated or continue to decline despite treatment with available DMTs. Thus there is an enduring need for safe and effective treatments for this underserved population." @default.
• W4386531127 created "2023-09-09" @default.
• W4386531127 creator A5000244655 @default.
• W4386531127 creator A5011585957 @default.
• W4386531127 creator A5018076822 @default.
• W4386531127 creator A5022579540 @default.
• W4386531127 creator A5067690675 @default.
• W4386531127 creator A5082371782 @default.
• W4386531127 date "2023-09-08" @default.
• W4386531127 modified "2023-09-28" @default.
• W4386531127 title "Treatment Patterns and Unmet Need for Patients with Progressive Multiple Sclerosis in the United States: Survey Results from 2016 to 2021" @default.
• W4386531127 cites W1993448410 @default.
• W4386531127 cites W2005585423 @default.
• W4386531127 cites W2016580451 @default.
• W4386531127 cites W2031431973 @default.
• W4386531127 cites W2038054049 @default.
• W4386531127 cites W2050678367 @default.
• W4386531127 cites W2058058932 @default.
• W4386531127 cites W2084033141 @default.
• W4386531127 cites W2096382053 @default.
• W4386531127 cites W2105206040 @default.
• W4386531127 cites W2105786767 @default.
• W4386531127 cites W2119172537 @default.
• W4386531127 cites W2140581746 @default.
• W4386531127 cites W2142577589 @default.
• W4386531127 cites W2174264037 @default.
• W4386531127 cites W2340863388 @default.
• W4386531127 cites W2508796864 @default.
• W4386531127 cites W2565433170 @default.
• W4386531127 cites W2565666036 @default.
• W4386531127 cites W2616110270 @default.
• W4386531127 cites W2783551928 @default.
• W4386531127 cites W2790816436 @default.
• W4386531127 cites W2890349017 @default.
• W4386531127 cites W2892471745 @default.
• W4386531127 cites W2896428764 @default.
• W4386531127 cites W2897587086 @default.
• W4386531127 cites W2904716724 @default.
• W4386531127 cites W2907044047 @default.
• W4386531127 cites W2911658427 @default.
• W4386531127 cites W2922308600 @default.
• W4386531127 cites W2967983128 @default.
• W4386531127 cites W2986102717 @default.
• W4386531127 cites W3001924147 @default.
• W4386531127 cites W3020773444 @default.
• W4386531127 cites W3027572432 @default.
• W4386531127 cites W3037954235 @default.
• W4386531127 cites W3039445169 @default.
• W4386531127 cites W3042308502 @default.
• W4386531127 cites W3093315457 @default.
• W4386531127 cites W3096310943 @default.
• W4386531127 cites W3108251659 @default.
• W4386531127 cites W3109586017 @default.
• W4386531127 cites W3113553077 @default.
• W4386531127 cites W3138599141 @default.
• W4386531127 cites W4212964378 @default.
• W4386531127 cites W4240696954 @default.
• W4386531127 cites W4281650051 @default.
• W4386531127 cites W4308861275 @default.
• W4386531127 doi "https://doi.org/10.1007/s40120-023-00532-2" @default.
• W4386531127 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37682512" @default.
• W4386531127 hasPublicationYear "2023" @default.
• W4386531127 type Work @default.
• W4386531127 citedByCount "0" @default.
• W4386531127 crossrefType "journal-article" @default.
• W4386531127 hasAuthorship W4386531127A5000244655 @default.
• W4386531127 hasAuthorship W4386531127A5011585957 @default.
• W4386531127 hasAuthorship W4386531127A5018076822 @default.
• W4386531127 hasAuthorship W4386531127A5022579540 @default.
• W4386531127 hasAuthorship W4386531127A5067690675 @default.
• W4386531127 hasAuthorship W4386531127A5082371782 @default.
• W4386531127 hasBestOaLocation W43865311271 @default.
• W4386531127 hasConcept C118552586 @default.
• W4386531127 hasConcept C126322002 @default.
• W4386531127 hasConcept C16568411 @default.
• W4386531127 hasConcept C1862650 @default.
• W4386531127 hasConcept C2778822529 @default.
• W4386531127 hasConcept C2778843634 @default.
• W4386531127 hasConcept C2779134260 @default.
• W4386531127 hasConcept C2779338263 @default.
• W4386531127 hasConcept C2780640218 @default.
• W4386531127 hasConcept C2780653079 @default.
• W4386531127 hasConcept C71924100 @default.
• W4386531127 hasConceptScore W4386531127C118552586 @default.
• W4386531127 hasConceptScore W4386531127C126322002 @default.
• W4386531127 hasConceptScore W4386531127C16568411 @default.
• W4386531127 hasConceptScore W4386531127C1862650 @default.
• W4386531127 hasConceptScore W4386531127C2778822529 @default.
• W4386531127 hasConceptScore W4386531127C2778843634 @default.
• W4386531127 hasConceptScore W4386531127C2779134260 @default.
• W4386531127 hasConceptScore W4386531127C2779338263 @default.
• W4386531127 hasConceptScore W4386531127C2780640218 @default.
• W4386531127 hasConceptScore W4386531127C2780653079 @default.
• W4386531127 hasConceptScore W4386531127C71924100 @default.
• W4386531127 hasFunder F4320316469 @default.
• W4386531127 hasLocation W43865311271 @default.
• W4386531127 hasLocation W43865311272 @default.
• W4386531127 hasOpenAccess W4386531127 @default.
• W4386531127 hasPrimaryLocation W43865311271 @default.
• W4386531127 hasRelatedWork W1991750545 @default.

• next